amitriptyline has been researched along with flurazepam in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| How, J; Strachan, RW | 1 |
| Cavanagh, RJ; Clifford, JS; Griffith, WL; Kluger, NJ | 1 |
| Goodwin, GM; Gray, JA; Green, AR; Heal, DJ | 1 |
| Cassano, GB; Conti, L; Fornaro, P; Levine, J; Massimetti, G | 1 |
| Hassanzadeh, A; Hassanzadeh, P | 1 |
1 review(s) available for amitriptyline and flurazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for amitriptyline and flurazepam
| Article | Year |
|---|---|
A double-blind clinical trial of nomifensine vs. amitriptyline in depressed patients.
Topics: Adult; Aged; Amitriptyline; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Flurazepam; Hospitals, Psychiatric; Humans; Isoquinolines; Male; Middle Aged; Nomifensine; Psychiatric Status Rating Scales; Random Allocation | 1982 |
6 other study(ies) available for amitriptyline and flurazepam
| Article | Year |
|---|---|
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Acute dilatation of stomach as late complication of drug overdose.
Topics: Acute Disease; Adolescent; Amitriptyline; Anti-Anxiety Agents; Female; Flurazepam; Gastric Dilatation; Humans; Orphenadrine | 1976 |
A case of a chemically dependent patient with a thalamic pain syndrome treated with amitriptyline.
Topics: Alcoholism; Amitriptyline; Cerebral Infarction; Flurazepam; Follow-Up Studies; Humans; Male; Middle Aged; Pain, Intractable; Recurrence; Sick Role; Substance Abuse Treatment Centers; Substance-Related Disorders; Thalamic Diseases | 1991 |
Hypothermia induced by baclofen, a possible index of GABAB receptor function in mice, is enhanced by antidepressant drugs and ECS.
Topics: 5,7-Dihydroxytryptamine; Amitriptyline; Animals; Antidepressive Agents; Baclofen; Body Temperature; Electroshock; Flurazepam; Hypnotics and Sedatives; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mice; Neural Pathways; Pentobarbital; Receptors, GABA-A | 1987 |
Implication of NGF and endocannabinoid signaling in the mechanism of action of sesamol: a multi-target natural compound with therapeutic potential.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Antioxidants; Benzodioxoles; Brain; Camphanes; Dose-Response Relationship, Drug; Endocannabinoids; Flurazepam; Injections, Intraperitoneal; Male; Molecular Targeted Therapy; Nerve Growth Factor; Phenols; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction | 2013 |